PURE BIOSCIENCE, INC. (PURE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue Quarterly

0 1.5M 3M 4.5M Q1 '12: 257K Q2 '12: 221K Q3 '12: 207K Q4 '12: 127K Q3 '17: 338K Q1 '18: 464K Q2 '18: 411K Q3 '18: 390K Q4 '18: 509K Q1 '19: 590K Q2 '19: 394K Q3 '19: 312K Q4 '19: 613K Q1 '20: 398K Q2 '20: 349K Q3 '20: 2.2M Q4 '20: 3.9M Q1 '21: 1.6M Q2 '21: 916K Q3 '21: 561K Q4 '21: 859K Q1 '22: 501K Q2 '22: 416K Q3 '22: 524K Q4 '22: 412K Q1 '23: 471K Q2 '23: 397K Q3 '23: 407K Q4 '23: 602K Q1 '24: 722K Q2 '24: 326K Q3 '24: 441K Q4 '24: 474K Q1 '25: 556K Q2 '25: 391K Q3 '25: 491K Q4 '25: 764K Q1 '26: 708K Q2 '26: 444K Q3 '26: 506K Q3 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Gross Profit Quarterly

0 800K 1.6M 2.4M Q1 '20: 242K Q2 '20: 207K Q3 '20: 1.2M Q4 '20: 2.3M Q1 '21: 950K Q2 '21: 553K Q3 '21: 315K Q4 '21: 257K Q1 '22: 329K Q2 '22: 234K Q3 '22: 325K Q4 '22: 112K Q1 '23: 257K Q2 '23: 197K Q3 '23: 196K Q4 '23: 321K Q1 '24: 442K Q2 '24: 177K Q3 '24: 258K Q4 '24: 275K Q1 '25: 325K Q2 '25: 227K Q3 '25: 283K Q4 '25: 468K Q1 '26: 450K Q2 '26: 238K Q3 '26: 269K Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Operating Income Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q4 '16: -1.4M Q1 '17: -1.6M Q2 '17: -1.4M Q3 '17: -1.6M Q4 '17: -1.4M Q1 '18: -1.9M Q2 '18: -2M Q3 '18: -1.7M Q4 '18: -1.4M Q1 '19: -2.6M Q2 '19: -1.3M Q3 '19: -912K Q4 '19: -822K Q1 '20: -1.1M Q2 '20: -663K Q3 '20: 474K Q4 '20: 1.3M Q1 '21: -179K Q2 '21: -594K Q3 '21: -810K Q4 '21: -728K Q1 '22: -795K Q2 '22: -940K Q3 '22: -759K Q4 '22: -1.2M Q1 '23: -986K Q2 '23: -1.1M Q3 '23: -875K Q4 '23: -1M Q1 '24: -711K Q2 '24: -964K Q3 '24: -817K Q4 '24: -699K Q1 '25: -627K Q2 '25: -725K Q3 '25: -584K Q4 '25: -336K Q1 '26: -379K Q2 '26: -683K Q3 '26: -518K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Net Income Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q4 '16: -679K Q1 '17: -1.7M Q2 '17: -936K Q3 '17: -1.7M Q4 '17: -1.8M Q1 '18: -2.3M Q2 '18: -2M Q3 '18: -1.7M Q4 '18: -1.4M Q1 '19: -2.6M Q2 '19: -1.3M Q3 '19: -1.9M Q4 '19: -819K Q1 '20: -1.1M Q2 '20: -666K Q3 '20: 473K Q4 '20: 1.3M Q1 '21: -180K Q2 '21: -595K Q3 '21: -811K Q4 '21: -733K Q1 '22: -796K Q2 '22: -702K Q3 '22: -760K Q4 '22: -1.2M Q1 '23: -993K Q2 '23: -1.1M Q3 '23: -876K Q4 '23: -1M Q1 '24: -735K Q2 '24: -1M Q3 '24: -857K Q4 '24: -756K Q1 '25: -689K Q2 '25: -798K Q3 '25: -580K Q4 '25: -332K Q1 '26: -464K Q2 '26: -785K Q3 '26: -624K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Cost of Revenue Quarterly

0 600K 1.2M 1.8M Q3 '17: 132K Q4 '17: 229K Q1 '18: 146K Q2 '18: 161K Q3 '18: 166K Q4 '18: 290K Q1 '19: 203K Q2 '19: 160K Q3 '19: 117K Q4 '19: 248K Q1 '20: 156K Q2 '20: 142K Q3 '20: 972K Q4 '20: 1.6M Q1 '21: 641K Q2 '21: 363K Q3 '21: 246K Q4 '21: 602K Q1 '22: 172K Q2 '22: 182K Q3 '22: 199K Q4 '22: 300K Q1 '23: 214K Q2 '23: 200K Q3 '23: 211K Q4 '23: 281K Q1 '24: 280K Q2 '24: 149K Q3 '24: 183K Q4 '24: 199K Q1 '25: 231K Q2 '25: 164K Q3 '25: 208K Q4 '25: 296K Q1 '26: 258K Q2 '26: 206K Q3 '26: 237K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating Cash Flow Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '16: -1.3M Q4 '16: -1.3M Q1 '17: -1M Q2 '17: -1.2M Q3 '17: -1.2M Q4 '17: -1.2M Q1 '18: -1M Q2 '18: -1.1M Q3 '18: -1.1M Q4 '18: -664K Q1 '19: -1.1M Q2 '19: -441K Q3 '19: -833K Q4 '19: -656K Q1 '20: -324K Q2 '20: -614K Q3 '20: -224K Q1 '21: -199K Q2 '21: -209K Q3 '21: -347K Q4 '21: -412K Q1 '22: -576K Q2 '22: -630K Q3 '22: -609K Q4 '22: -603K Q1 '23: -902K Q2 '23: -967K Q3 '23: -665K Q4 '23: -744K Q1 '24: -440K Q2 '24: -883K Q3 '24: -615K Q4 '24: -593K Q1 '25: -503K Q2 '25: -544K Q3 '25: -512K Q4 '25: -456K Q1 '26: -250K Q2 '26: -606K Q3 '26: -468K Q3 '17 Q4 '18 Q1 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Free Cash Flow Quarterly

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q2 '12: -1.3M Q3 '12: -1.2M Q4 '12: -1.6M Q1 '13: -1.2M Q2 '13: -1.5M Q3 '13: -812K Q4 '13: -384K Q1 '14: -2.3M Q2 '14: -1.8M Q3 '14: -1.4M Q4 '14: -947K Q3 '15: -1.4M Q4 '15: -1.2M Q3 '16: -1.4M Q4 '16: -1.3M Q1 '17: -1.1M Q2 '17: -1.3M Q3 '17: -1.2M Q4 '17: -1.2M Q1 '18: -1M Q2 '18: -1.1M Q3 '18: -1.1M Q4 '18: -664K Q1 '19: -1.1M Q2 '19: -441K Q3 '19: -835K Q4 '19: -657K Q3 '20: -224K Q1 '21: -373K Q2 '21: -539K Q3 '21: -347K Q4 '21: -429K Q1 '22: -630K Q2 '22: -631K Q3 '22: -620K Q4 '22: -620K Q1 '23: -939K Q2 '23: -967K Q3 '23: -704K Q4 '23: -787K Q2 '13 Q3 '14 Q4 '16 Q1 '18 Q2 '19 Q2 '21 Q3 '22 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q3 '15: 40.8M Q3 '16: 71.3M Q3 '17: 62.7M Q3 '19: 76.6M Q3 '20: 85.7M Q3 '21: 87.2M Q1 '22: 87.4M Q2 '22: 87.9M Q3 '22: 87.9M Q1 '23: 111.4M Q2 '23: 111.4M Q3 '23: 111.4M Q1 '24: 111.9M Q2 '24: 111.9M Q3 '24: 111.9M Q1 '25: 111.9M Q2 '25: 111.9M Q3 '25: 111.9M Q1 '26: 111.9M Q2 '26: 111.9M Q3 '26: 110.8M Q3 '17 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q4 '15: -0.18 Q1 '16: -0.20 Q2 '16: -0.35 Q3 '17: -0.04 Q4 '17: -0.10 Q1 '18: -0.11 Q2 '18: -0.13 Q3 '18: -0.12 Q4 '18: -0.11 Q1 '19: -0.11 Q2 '19: -0.10 Q3 '19: -0.11 Q4 '19: -0.10 Q1 '20: -0.07 Q2 '20: -0.06 Q3 '20: -0.02 Q4 '20: 0.00 Q1 '21: 0.01 Q2 '21: 0.01 Q3 '21: -0.01 Q4 '21: -0.03 Q1 '22: -0.04 Q2 '22: -0.04 Q3 '22: -0.04 Q4 '22: -0.04 Q1 '23: -0.04 Q2 '23: -0.05 Q3 '23: -0.05 Q4 '23: -0.05 Q1 '24: -0.05 Q2 '24: -0.04 Q3 '24: -0.04 Q4 '24: -0.03 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.02 Q2 '26: -0.02 Q3 '26: -0.02 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.